pla725
Well-Known Member
It's reported in this quarter's Rabbiting On (the magazine of the Rabbit Welfare Association and Fund) that RWF has awarded a grant to vets Sharon Redrobe and Richard Saunders of the Bristol University Rabbit Clinic, so that an important study can be carried out into the effectiveness of toxicity of the different treatment regimes that are recommended to treat E Cuniculi. Although some research has been carried out in recent years into EC in rabbits, there is still much that needs to be learnt about the infection.
The article goes on to say that the study will involve diagnosing EC infection in apparently healthy pet rabbits using a variety of tests that are commonly used by vets in practice Positive rabbits will then be treated with the currently recommended medicine, fenbendazole, for varying periods of time, as suggested by different manufacturers.
The rabbits will be monitored carefully for any adverse side effects of the medication. If any harmful side effects are noted then treatment will stop immediately and the rabbits will be treated appropriately to recover. the rabbits will also be closely monitored to see what happens to the antibody levels and shedding of the parasite via the urine during and after treatment. In this way the study will discover a number of things - whether the treatment stops parasite shedding via the urine and how quickly, how treatment affects the antibody levels, how long the treatment takes to act and what length of treatment might be best to treat the parasite yet avoid any problems in the rabbit. It will also reveal whether longer or shorter courses of the treatment badly affect the rabbit at all.
Sharone Redrobe said, "This will all lead to a better understanding of what we are using this medication for and how well it works under different circumstances. This is an exciting study which will reveal a lot about this commonly diagnosed disease. We will be working on this project over the summer and will report back with the results later in the year."
The article goes on to say that the study will involve diagnosing EC infection in apparently healthy pet rabbits using a variety of tests that are commonly used by vets in practice Positive rabbits will then be treated with the currently recommended medicine, fenbendazole, for varying periods of time, as suggested by different manufacturers.
The rabbits will be monitored carefully for any adverse side effects of the medication. If any harmful side effects are noted then treatment will stop immediately and the rabbits will be treated appropriately to recover. the rabbits will also be closely monitored to see what happens to the antibody levels and shedding of the parasite via the urine during and after treatment. In this way the study will discover a number of things - whether the treatment stops parasite shedding via the urine and how quickly, how treatment affects the antibody levels, how long the treatment takes to act and what length of treatment might be best to treat the parasite yet avoid any problems in the rabbit. It will also reveal whether longer or shorter courses of the treatment badly affect the rabbit at all.
Sharone Redrobe said, "This will all lead to a better understanding of what we are using this medication for and how well it works under different circumstances. This is an exciting study which will reveal a lot about this commonly diagnosed disease. We will be working on this project over the summer and will report back with the results later in the year."